Indication
Gender
2 clinical trials
2 products
Clinical trial
Observational Study on Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Radioiodine Refractory Differentiated Thyroid CancerStatus: Recruiting, Estimated PCD: 2024-07-31
Product
LenvatinibClinical trial
Transgender Youth and PrEP: PK, Safety, Uptake & AdherenceStatus: Completed, Estimated PCD: 2023-11-30
Product
TDF/FTC